Eric Swayze

CIK: 0001791058

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)21 (44.7%)

Position reduction

Option Exercises (M)11 (23.4%)

Derivative conversions

Awards (A)12 (25.5%)

Compensation grants

Other (G, F, J, C, D, …)3 (6.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IONS

IONIS PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (47 total)

IONS
IONIS PHARMACEUTICALS INC
Oct 16, 2026
Sale(S)
Indirect
53 shares at avg. $43.54$2K
IONS
IONIS PHARMACEUTICALS INC
Oct 15, 2026
Exercise(M)
Indirect
125 shares-
IONS
IONIS PHARMACEUTICALS INC
Jun 25, 2026
Sale(S)
Direct
10.6K shares at avg. $79.18$839K
IONS
IONIS PHARMACEUTICALS INC
Feb 27, 2026
Other(J)
Direct
256 shares at avg. $48.87$13K
IONS
IONIS PHARMACEUTICALS INC
Feb 13, 2026
Sale(S)
Direct
6.2K shares at avg. $82.07$509K
IONS
IONIS PHARMACEUTICALS INC
Feb 13, 2026
Sale(S)
Direct
9.4K shares at avg. $81.56$770K
IONS
IONIS PHARMACEUTICALS INC
Jan 30, 2026
Sale(S)
Direct
6.2K shares at avg. $82.93$512K
IONS
IONIS PHARMACEUTICALS INC
Jan 29, 2026
Award(A)
Direct
12K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 16, 2026
Sale(S)
Indirect
49 shares at avg. $75.97$4K
IONS
IONIS PHARMACEUTICALS INC
Jan 16, 2026
Sale(S)
Direct
9.9K shares at avg. $75.34$745K
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Restricted Stock Unit
Indirect
225 shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Exercise(M)
Direct
21.4K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Exercise(M)
Indirect
111 shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Performance Restricted Stock Units
Direct
25.8K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Restricted Stock Unit
Direct
9.7K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Exercise(M)
Direct
5.1K shares at avg. $60.89$312K
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Sale(S)
Direct
18.3K shares at avg. $79.27$1.5M
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Award(A)
Non-Qualified Stock Option (right to buy)
Indirect
150 shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
19.4K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Sale(S)
Direct
5.1K shares at avg. $78.57$403K
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Exercise(M)
Direct
18.3K shares at avg. $60.89$1.1M
IONS
IONIS PHARMACEUTICALS INC
Oct 16, 2025
Sale(S)
Indirect
53 shares at avg. $73.62$4K
IONS
IONIS PHARMACEUTICALS INC
Oct 15, 2025
Exercise(M)
Indirect
125 shares-
IONS
IONIS PHARMACEUTICALS INC
Oct 6, 2025
Sale(S)
Direct
6.8K shares at avg. $69.02$473K
IONS
IONIS PHARMACEUTICALS INC
Oct 2, 2025
Exercise(M)
Direct
13K shares at avg. $53.77$698K

		Type	Shares	Price		Ownership
Oct 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	53	$43.54	$2,308	Indirect
Oct 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	125	-	$0	Indirect
Jun 25, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	10,602	$79.18	$839,492	Direct
Feb 27, 2026	IONS IONIS PHARMACEUTICALS INC	Other(J)	256	$48.87	$12,510	Direct
Feb 13, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	6,207	$82.07	$509,403	Direct
Feb 13, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	9,435	$81.56	$769,511	Direct
Jan 30, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	6,179	$82.93	$512,446	Direct
Jan 29, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A)	11,991	-	$0	Direct
Jan 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	49	$75.97	$3,723	Indirect
Jan 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	9,884	$75.34	$744,661	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Restricted Stock Unit	225	-	-	Indirect
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	21,366	-	$0	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	111	-	$0	Indirect
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Performance Restricted Stock Units	25,800	-	-	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Restricted Stock Unit	9,675	-	-	Direct
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	5,125	$60.89	$312,061	Direct
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	18,338	$79.27	$1,453,653	Direct
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Non-Qualified Stock Option (right to buy)	150	-	-	Indirect
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Non-Qualified Stock Option (right to buy)	19,350	-	-	Direct
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	5,125	$78.57	$402,671	Direct
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	18,338	$60.89	$1,116,601	Direct
Oct 16, 2025	IONS IONIS PHARMACEUTICALS INC	Sale(S)	53	$73.62	$3,902	Indirect
Oct 15, 2025	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	125	-	-	Indirect
Oct 6, 2025	IONS IONIS PHARMACEUTICALS INC	Sale(S)	6,849	$69.02	$472,718	Direct
Oct 2, 2025	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	12,972	$53.77	$697,504	Direct

1-25 of 47 transactions

About Swayze Eric

Swayze Eric (SEC CIK 0001791058) files insider reports with the SEC as EVP Research of IONIS PHARMACEUTICALS INC (IONS).

Signal8 holds 19 ownership filings by Swayze Eric, all Form 4s, filed between Sep 4, 2024 and Oct 19, 2026. Those filings report 47 transactions, from Feb 2, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Swayze Eric's filings is in CARLSBAD, CA.

Recent filings by Swayze Eric

Oct 16, 2026: Open-market sale of IONS shares (Form 4, code S).
Oct 15, 2026: Option exercise of IONS shares (Form 4, code M).
Jun 25, 2026: Open-market sale of IONS shares (Form 4, code S).
Feb 27, 2026: Other transaction of IONS shares (Form 4, code J).
Feb 13, 2026: Open-market sales of IONS shares (2 lines, Form 4, code S).

Other insiders filing for IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L., EVP, Chief Human Resources Ofc
BENNETT C FRANK, EVP, Chief Scientific Officer
O'NEIL PATRICK R., EVP CLO & General Counsel
Monia Brett P, Chief Executive Officer
Birchler Brian, EVP, Corp and Development Ops
Hayden Michael R, Director

How to read Form 4 transaction codes